• 
  Mila Collados Rodríguez, Patrick Maillard, Alexandra Journeaux, Anastassia Komarova, Valérie Najburg, et al.. Novel Antiviral Molecules against Ebola Virus Infection. International Journal of Molecular Sciences, 2023, 24 (19), pp.14791. ⟨10.3390/ijms241914791⟩. ⟨hal-04628707⟩
• 
  Caroline Marnata, Aure Saulnier, Dimitri Mompelat, Thomas Krey, Lisette Cohen, et al.. Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction. Journal of Virology, 2015, 89 (23), pp.12131-12144. ⟨10.1128/jvi.01161-15⟩. ⟨hal-04631765⟩
• 
  Marie Pouquet, Dorine Decarreaux, Laura Di Domenico, Chiara Sabbatini, Pol Prévot-Monsacre, et al.. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave. Scientific Reports, 2024, 14 (1), pp.5418. ⟨10.1038/s41598-024-55477-9⟩. ⟨hal-04494616⟩
• 
  Shigeru Fujita, Arnon Plianchaisuk, Sayaka Deguchi, Hayato Ito, Naganori Nao, et al.. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236. EBioMedicine, In press, 104, pp.105181. ⟨10.1016/j.ebiom.2024.105181⟩. ⟨pasteur-04601481⟩
• 
  Sham Nambulli, Nicolas Escriou, Linda J. Rennick, Matthew J. Demers, Natasha L Tilston-Lunel, et al.. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of Virology, 2024, 98 (5), pp.e01762-23. ⟨10.1128/jvi.01762-23⟩. ⟨pasteur-04601196⟩

188

27